Advances in Immuno-Oncology for CNS Tumors

This track invites abstracts on the latest developments in immuno-oncology for central nervous system (CNS) tumors. Researchers should focus on novel immunotherapeutic approaches, including immune checkpoint inhibitors, CAR-T cell therapy, and vaccines targeting CNS malignancies. Submissions that address the unique challenges of treating brain tumors, such as the blood-brain barrier and tumor microenvironment, are highly encouraged. Attendees will learn about the cutting-edge research that is driving new treatment options for CNS tumors, offering hope for improved outcomes in this challenging field.

    Related Conference of Advances in Immuno-Oncology for CNS Tumors

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Advances in Immuno-Oncology for CNS Tumors Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in